Intellinetics, Inc. (INLX) Misses Q2 EPS by 17c

Intellinetics, Inc. (OTC: INLX) reported Q2 EPS of ($0.24), $0.17 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $3.94 million versus the consensus estimate of $4.87 million.

For earnings history and earnings-related data on Intellinetics, Inc. (INLX) click here.

You May Also Be Interested In

• Raymond James Starts SpyGlass Pharma (SGP) at Outperform
• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18